Ultragenyx Pharmaceutical | RARE - Себестоимость





Себестоимость Изменить Дата
Acadia Pharmaceuticals USD 28.32M 3.52M 2026-06
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Alnylam Pharmaceuticals USD 298.45M 87.33M 2026-06
BioCryst Pharmaceuticals USD 3.84M 5.68M 2026-06
BioMarin Pharmaceutical USD 276.29M 76.8M 2026-06
Insmed USD 69.29M 19.79M 2026-06
Ionis Pharmaceuticals USD 2.74M 261K 2026-06
Karyopharm Therapeutics USD 1.34M 139K 2026-03
Kyowa Hakko Kirin JPY 39.13B 6.13B 2026-06
MacroGenics USD 9.53M 585K 2026-03
Moderna USD 93M 862M 2026-06
Neurocrine Biosciences USD 39.4M 25.6M 2026-06
PTC Therapeutics USD 39.61M 23.31M 2026-03
Puma Biotechnology USD 29.1M 18.44M 2024-09
Regeneron Pharmaceuticals USD 576.5M 92.9M 2026-06
Sarepta Therapeutics USD 150.1M 40.64M 2026-06
Ultragenyx Pharmaceutical USD 30M 1000K 2026-03
Vertex Pharmaceuticals USD 489.2M 96.4M 2026-06